Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Week In Review: WuXi AppTec And Juno Form China Immuno-Oncology JV

By: TalkMarkets
WuXi AppTec, China's largest CRO/CMO, and Juno Therapeutics of Seattle have formed a 50-50 joint venture to bring Juno's promising immuno-oncology drugs to China.
Related Stocks:
Alibaba Group Holding Ltd Sorrento Therapeutics Inc
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.